Biotech PYC seeks $653m cash via new equity raising
SYDNEY: PYC Therapeutics, a developer of RNA therapies for genetic diseases and capitalised ... read more
SYDNEY: PYC Therapeutics, a developer of RNA therapies for genetic diseases and capitalised ... read more